United Kingdom Molecular Diagnostics Market to be Dominated by Reagents Segment Through 2028
Increasing demand for genetic testing and
expanding diagnostic technologies are expected to drive the United Kingdom Molecular
Diagnostics Market in the forecast period, 2024-2028.
According
to TechSci Research report, “United Kingdom Molecular Diagnostics Market – By Region,
Competition Forecast and Opportunities, 2018-2028F,” the United Kingdom Molecular Diagnostics Market is anticipated to grow
at a significant rate in the forecast period, f 2024-2028. The molecular
diagnostics market in the United Kingdom is witnessing significant growth,
driven by the increasing prevalence of chronic diseases among the rising
geriatric population. One of the main reasons the geriatric population is
driving the molecular diagnostics market is the higher incidence of age-related
diseases. As people age, they become more susceptible to various health
conditions such as cancer, cardiovascular diseases, neurological disorders, and
infectious diseases. Molecular diagnostics offer precise and early detection of
these conditions, allowing for timely intervention and personalized treatment
plans. The ability to detect diseases at their molecular level enables
healthcare providers to tailor therapies and medications specifically to each
patient, improving overall outcomes. With advancements in technology, there has
been a notable increase in public awareness regarding the role of genetics in
disease susceptibility. Individuals are becoming more conscious of the
potential genetic factors contributing to various conditions, including cancer,
cardiovascular diseases, and rare genetic disorders. This heightened awareness
has prompted more people to seek genetic testing as a means of gaining valuable
insights into their risk profiles, facilitating early detection, and enabling
proactive healthcare management, which is expected to propel the growth of the
United Kingdom Molecular Diagnostics Market in the forecast period.
However, with the growing demand for molecular
diagnostics, challenges such as cost, and accessibility need to be addressed.
Molecular diagnostics often involve complex laboratory processes and can be
expensive. Ensuring affordability and equitable access to these diagnostic
tests will be crucial to fully harness their potential in the geriatric population,
which may hamper the growth of the market in the forecast period.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
“United Kingdom Molecular Diagnostics Market “.
The
United Kingdom Molecular Diagnostics Market is categorized into Component,
Technology, Application, End User, and Company.
In
terms of Component, the market is segmented into Instruments, Reagents,
Software, and Services. Reagents are projected to experience growth during the
forecast period due to their immense necessity for conducting various research
measures such as genetic material extraction, protein and biomolecule
separation, and genetic material amplification.
Based
on technology, the market is categorized into PCR, DNA Sequencing,
Hybridization, Microarray, INAAT, and Others. PCR (polymerase chain reaction)
is projected to experience growth during the forecast period owing to its rapid
amplification of specific DNA segments, facilitating improved diagnosis.
Based
on application, the market is segmented into Oncology, Infectious Disease
Testing, Genetic Testing, and Others. Infectious Disease Testing is expected to
demonstrate growth during the forecast period, driven by the high prevalence of
infectious diseases in the United Kingdom.
In
terms of end user, the market is divided into Hospitals & Clinics,
Diagnostic Laboratories, and Others. The Hospitals & Clinics segment is
anticipated to witness growth during the forecast period, attributed to the
availability of comprehensive inpatient and outpatient medication facilities,
as well as certified healthcare professionals. These factors contribute to the
overall growth of the United Kingdom Molecular Diagnostics market.
Major
companies operating in the United Kingdom Molecular Diagnostics Market are:
- Johnson
& Johnson Services, Inc.
- Abbott
Laboratories Ltd.
- Siemens
Healthineers AG
- Hologic
Inc.
- Qiagen
N.V.
- Becton,
Dickinson and Company Ltd.
- bioMérieux SA
- Agilent Technologies Inc.
- Bio-Rad
Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
Download
Free Sample Report
Customers can also request for 10% free
customization on this report.
“The United Kingdom Molecular
Diagnostics Market is poised for substantial growth in the coming years, driven
by continuous technological advancements in healthcare diagnosis within the
nation. The rising healthcare investments and government initiatives for
research and innovation will fuel significant market expansion in the United
Kingdom. Furthermore, the increasing technological advancements in the medical
radiation diagnostics industry and the growing number of hospitals in the
nation will further augment the market's growth trajectory, which is expected
to continue through 2028,” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based global management consulting firm.
“United Kingdom Molecular Diagnostics Market By Component (Instruments, Reagents, Software, Services), By Technology
(PCR, DNA Sequencing, Hybridization, Microarray, INAAT, Others), By Application
(Oncology, Infectious Disease Testing, Genetic Testing, Others), By End User (Hospitals
& Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast &
Opportunities, 2018-2028F” has
evaluated the future growth potential of the United Kingdom Molecular
Diagnostics Market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the United Kingdom Molecular
Diagnostics Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com